| O-SEMA-Fast: A research study to understand how oral semaglutide works in people with type 2 diabetes who plan to fast during Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait |
Ongoing |
Semaglutide |
4 |
NN9924-757 |
Almoosa Specialist Hospital (Alahsa) |
| Study on Clinical Use of EVUSHELD (AZD7442) as Pre-exposure Prophylaxis in the Real-world Setting – A Multi-centre Observational Prospective Study to Determine the Utilisation and Clinical Outcomes of EVUSHELD in Middle East and Africa |
Ongoing |
EVUSHELD |
4 |
D8851R0000 |
King Saud Medical City (Riyadh) |
| A REGISTRY TO COLLECT CHARACTERISTICS AND OUTCOMES FROM PATIENTS WITH SOLID TUMORSPROFILED WITH A NEXT-GENERATION SEQUENCINGTEST (WAYFIND-R) |
Ongoing |
NA |
4 |
MX39897 |
King Abdulaziz Medical City NG (Riyadh) |
| Real-World Experience of Upadacitinib in Moderate to Severe Atopic Dermatitis |
Ongoing |
Upadacitinib (Rinvoq) |
4 |
H23-107 |
King Faisal General Hospital (Makkah), Mohammed Dossary Hospital - Al Khobar, King Fahad Central Hospital (Jazan), East Jeddah General Hospital, Hira Hospital (Makkah) , Aseer Central Hospital (Abha) |
| Articaine efficacy and safety for 3 years old children: A Clinical Randomized Control Trial. |
Ongoing |
Articaine |
3 |
607-43-7809 |
Qassim Regional Dental Center,The One Clinic (Buraydah) |
| An open label, multi-center asciminib roll-over study to assess long-term safety in patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment. |
Ongoing |
ABL001 (Asciminib), Imatinib, Nilotinib, Bosutinib |
3 |
CABL001A2001B |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| Palbociclib Combinations in HR+/HER2- Metastatic Breast Cancer Patients: A Non-Interventional Prospective Study on the Treatment Patterns & Clinical Outcomes in Africa Middle East (PRECIOUS) |
Ongoing |
PALBOCICLIB |
4 |
A5481150 |
King Fahad Specialist Hospital (Dammam) , King Abdulaziz Medical City NG (Riyadh) , King Khalid University Hospital (Riyadh) |
| Non-invasive ventilation and dexmedetomidine in critically ill adults: a vanguard pragmatic randomized controlled trial (inDEX trial) |
Ongoing |
dexmedetomidine , Non-invasive ventilation |
3 |
SCT22R/001/01 |
King Abdulaziz Medical City NG (Riyadh) |
| A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen |
Ongoing |
Nusinersen (Spinraza) |
3 |
232SM302 |
King Faisal Specialist Hospital and Research Center (Riyadh),King Fahad Specialist Hospital (Dammam),King Abdulaziz Medical City NG (Jeddah) |
| An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease |
Ongoing |
FT-4202 |
2/3 |
4202-HEM-301 |
King Khalid University Hospital (Riyadh),Prince Mohammad Bin Naser Hospital, Jizan, Saudi Arabia |
